Sold by: PwC
PwC accelerates the way pharmaceutical companies improve and streamline clinical trial protocol design decisions with AI-enabled insights and intelligent automation.
Overview
The Intelligent Clinical Trial (ICT) solution is an AI-driven platform that enhances trial design by enabling scenario planning during protocol design and planning phases. It leverages digitized and aggregated data from both internal and external sources to provide asset teams with data-driven recommendations for streamlining protocol design. By integrating sponsor and external protocol data with internal operational outcomes like costs and screen failures, ICT helps highlight potential changes in protocol design scenarios. This empowers teams to make informed decisions that align with scientific and operational goals, while AI models evaluate the impact of trial design decisions on metrics such as trial costs, screen failure risks, and patient and site burden.
The team will implement solutions in clients AWS environment through a structured professional services engagement.
Highlights
- Accelerated Timelines: Faster time to market and product launch (25% acceleration in timeline)
- Reduced Trial Costs: Improved operational efficiency and reduced study execution cost (40% cost avoidance)
- Reduced Patient Burden: Decreased patient burden enables lower discontinuation rates and improved patient diversity
Details
Pricing
Custom pricing options
Pricing is based on your specific requirements and eligibility. To get a custom quote for your needs, request a private offer.
Legal
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
Support
Vendor support
To learn more, please reach out to our PwC AWS Alliance Team via: us_aws_marketplace_sales@pwc.com